...of all tested Cox 2 inhibitors, that is. It was also the least studied of the NSAIDS they looked at. They conclude that naproxen seems least harmful, however the analysis did not consider GI side effects, only cardiovascular.
http://www.medscape.com/viewarticle/736039?src=mp&spon=27